Sun, Bin
Sengupta, Nilanjan
Rao, Anita
Donnelly, Charles
Waichale, Vinit
Roy, Arnab Sinha
Ramaswamy, Shilpa
Pathak, Divya
Bowsher, Ronald R.
Raiter, Yaron
Aubonnet, Patrick
Barve, Abhijit
Funding for this research was provided by:
Viatris, Inc
Biocon
Article History
Received: 26 February 2021
Accepted: 4 June 2021
First Online: 26 June 2021
Declarations
:
: Both INSTRIDE 1 and INSTRIDE 2 were conducted in accordance with the general principles set forth in the International Ethical Guidelines for Biomedical Research Involving Human Subjects, the International Council for Harmonization Guidelines for Good Clinical Practice, and the Declaration of Helsinki. The protocols were reviewed and approved by independent ethics committees/institutional review boards in accordance with local legal regulations. All patients provided written informed consent before enrollment in the study.
: Not applicable.
: BS, CD, YR, PA, and AB are paid employees of Viatris Inc and may hold stock or stock options in the company. NS, AR, and SR are paid employees of Biocon Research Limited and may hold stock or stock options in the company. VW, ASR, and DP were employees of Biocon Research Limited during the time of the study and may hold stock or stock options in the company. RRB has served as a consultant for Viatris Inc.